All Stories

Vor Bio to wind down, halting cell therapy trials and shedding most staff

Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff.

May 8, 2025 - 23:17
 0
Vor Bio to wind down, halting cell therapy trials and shedding most staff
Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff.
Read More

Tags:

Previous Article

FDA will fully adopt generative AI by end of June, Martin Makary says

Next Article

FDA appoints first chief AI officer as it looks to speed up reviews

Related Posts

German cancer antibody biotech eyes SPAC as route to Nasdaq

German cancer antibody biotech eyes SPAC as route to Na...

Apr 23, 2025  0

Sanofi’s oral TNF inhibitor misses mark in phase 2 psoriasis trial, prompting focus on combos

Sanofi’s oral TNF inhibitor misses mark in phase 2 psor...

Apr 24, 2025  0

Study illustrates pros, cons in AI readings of 3D mammography scans

Study illustrates pros, cons in AI readings of 3D mammo...

Apr 25, 2025  0